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ABSTRACT 
 
 The United States Food and Drug Administration (FDA) describes the development of medications 
to be a five step process which entails three direct steps located in the laboratory environment. These 
laboratory investigations include exploring the fundamental mechanisms governing the disease of interest 
as well as testing any drugs in the preclinical environment for a preliminary assessment of the potential 
impact of humans. The maximum preliminary assessment potential is in part constrained by the instruments 
available for exploring the small animals, generally mice, involved in the experiments. Nuclear instruments 
such X-ray, Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography 
(SPECT) are often implemented due to their ability to identify either the anatomical or physical features of 
interest. In this thesis, two state of the art nuclear modalities, X-Ray Fluorescence Emission Tomography 
(XFET) and CdTe Hybrid Pixel-Waveform (HPWF) PET, are evaluated as potentially complementary 
experimental preclinical instruments due the their combined ability to reveal biological information through 
the utilization of a broader portion of the electromagnetic spectrum with discussion directly focused on 
neurological applications.  
 The two independent experimental systems were evaluated for proof of concept in order establish 
the potential viability of imaging small transgenic animals. The first modality, a benchtop XFET system, 
used an incident monochromatic 17.4 keV beam with a slit mounted Andor Ikon-L Charge Coupled Device 
(CCD) with a featured pixelated element size of 13.5 µm x 13.5 µm. Samples for the XFET system were 
mounted on a 4-D stage capable of X-Y-Z translation with full rotation. Fluorescent emissions were 
measured from a triple tube capillary phantom composed of various chemical compositions in addition to 
a resin encased osmium stained zebrafish. Spectral results and imaging results are presented.   
The second modality was explored with an intent to better understand the maximum achievable 
spatial resolution.  A dual HWPF detector coincidence system composed of CdTe energy resolvable photon 
counting (ERPC) detectors was implemented with a field programmable gate array (FPGA) modifiable 
readout sequence of an 8 application specific integrated circuit (ASIC) layout per detector. Each ASIC 
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featured 64 x 32 pixelated elements of size 350 µm x 350 µm bump bonded to the under size of a 2 mm 
thick CdTe crystal with an area of 11 mm x 22 mm. The unique readout scheme of the HPWF detector 
design uses an external digitizer sampling at 200 Ms/s to save the cathode waveform and the anode 
waveform for each individual event for post processing. Experiments were performed using (A) a 10 µCi 
Na-22 source with a diameter of 250 µm, and (B) a set of 3 microcapillary tubes with sub 1 mm inner 
diameter.  
Keywords: XFET, CdTe, PET, Hybrid Pixel-Waveform, Energy Resolvable Photon Counting Detectors, 
Imaging, Transgenic Animals 
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CHAPTER 1. INTRODUCTION 
 The present mentality for broad spectrum nuclear imaging explores the integration of modalities 
such as PET and SPECT with magnetic resonance imaging (MRI). Substantial effort has been put into the 
integration due to the desire to obtain the high soft tissue contrast achievable with MRI with the functional 
imaging provided by PET and SPECT [1-3]. These efforts assist in the link between a function and anatomy. 
However, this integration serves only to provide a topical insight into any biology in question. This current 
state of the art correlates biological function to anatomical position rather than exploring the elements which 
could explain a function. Therefore, further efforts should explore the integration of modalities which can 
identify the fundamental function to the elements which govern the function. In this capacity, X-ray 
fluorescence (XRF), and PET or SPECT could serve as an ideal integration. This work describes the 
potential contributions each modality could provide to small animal neurological imaging while 
establishing the proof of concept for each individual instrument.  
1.1 Trace Metal Identification Using X-ray Fluorescence 
 Naturally occurring metal ions are well known to be critical in both disease, and physiological 
function [4-7]. The degree of our understanding would benefit greatly from imaging methods that could 
provide high resolution mapping of select metals in biological tissue. Efforts in imaging trace metals 
initially required the use of high flux source such as those only attainable at synchrotron facilities. 
Synchrotron-based X-ray fluorescence computed tomography (XFCT) typically employs a pencil beam of 
highly intense and monochromatic X-ray beam to illuminate the object. Among other interactions, the 
incident X-rays undergo photoelectric interactions with metal atoms, which will emit characteristic X-rays 
in response. The characteristic X-rays are collected by a non-spatially capable detector, and, in the absence 
of significant attenuation, the area of the measured characteristic X-ray peak can be directly related to the 
line integral through the elemental distribution map. The object is then scanned and rotated through the 
illumination beam in order to acquire a complete sinogram of line integrals in a first-generation tomographic 
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acquisition [8-14]. A standard analytic or iterative CT algorithm can then be used for image reconstruction, 
although in the presence of attenuation, alternative models and methods are needed. 
 In recent years, several groups have begun to study the potential of developing a benchtop version 
of XFCT using conventional sources [15], [10], [16]. The initial work has focused largely on organism-
scale imaging of metal-based nanoparticles at multi-millimeter resolutions. Most of these approaches also 
use a variation of the first-generation CT geometry, with measurement of one line integral at a time. We 
have been exploring an alternative geometry aimed at achieving 100 µm resolution in ex vivo biological 
specimens [12], [13]. We call the approach X-ray fluorescence emission tomography (XFET), and it 
couples apertures typically seen in emission tomography with position-sensitive X-ray imaging 
spectrometers. It still employs a pencil beam of X-rays to excite the metal atoms in the object, but now the 
fluorescence X-rays are detected by an imaging detector placed behind a slit aperture. The emissions from 
a small segment of the illumination line are thus imaged onto a column of the detector, and direct image 
“reconstruction” is possible without the need for solving an inverse problem.  
1.2 Semiconductor Positron Emission Tomography for Small Animal Neurological Imaging 
 PET and SPECT have served as very successful modalities for functional imaging over last many 
years. The modalities both utilize nuclear decay but differ due the mechanism of decay. SPECT relies on 
the use of a single gamma ray emitter and physical collimator to determine the projection path from the 
object space to the detector. PET exploits the use of the near co-linear annihilation gamma events to 
determine the projection path from the detector space to the object space, which is referred to as electronic 
collimation. The fundamental selection of the mean of decay results in the limitation and benefits of both 
modalities. SPECT, lacking the need for positron decay and thus the challenge of positron range, is 
identified as a higher spatial resolution modality, and, due to the lack of electronic collimation, is capable 
of resolving multiple tracers based on the emission energy of the characteristic gamma rays. PET benefits 
from having a higher sensitivity than SPECT and positron emitters better match the naturally occurring 
atoms within biology making the created radiotracers more chemically compatible. Currently, there are 
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many PET tracers developed for neurodegenerative applications, while the development of relevant SPECT 
tracers remains to be very limited [17-22]. 
 Initial efforts in developing small animal PET were reliant on the use of scintillation detectors due 
to their good timing ability. However, the basic operation principles of scintillation detectors has limited 
many commercial small animal imaging systems to above 1 mm [23]. This resolution applied to the brains 
of mice does not provide adequate spatial resolution for research applications. Efforts have been placed on 
identifying alternatives to scintillation detectors. This has led to many to explore highly pixelated 
semiconductor detectors. The challenges of implementing such detectors arise from the material selection 
used for photoelectric conversion. Works have identified CdTe and CZT as potentially viable options. 
However, there are still many challenges that need to be addressed within semiconductor devices such as 
charge trapping, parallax error, timing, and verification of the fundamental spatial resolution of these 
detectors. This thesis provides a preliminary exploration of the achievable spatial resolution.    
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CHAPTER 2. BACKGROUND OF PRECLINICAL NEURODEGENERATIVE DISEASE 
2.1 The Appearance of Alzheimer’s Disease 
 In Germany in the early 1900s, a family expressed concern when the wife began to express very 
odd behavior. At the age of 51 years old, Auguste Deter, wife of Karl Deter, showed significant cognitive 
impairment. She experienced loss of memory, delusions, sleeping difficultly, and would at times wake her 
husband in the middle of the night screaming [24]. Given the lack of neurological understanding at the time, 
Karl Deter admitted his wife to the Institute for the Mentally Ill and Epileptics in Frankfurt Germany in 
1901 where the family met Dr. Alois Alzheimer. Dr. Alois Alzheimer had recently begun working very 
intensely in the hospital to cope with the death of his wife who had left him with their three children behind 
[25].  
 The time shared between Dr. Alzheimer and Auguste Deter was brief. However his analysis quickly 
identified that she had a disease of forgetfulness. Notes rediscovered in showed that he would ask a series 
of questions in the morning only to return later that day to find Mrs. Deter completely nonsensical [25]. 
Her condition greatly interested Dr. Alzheimer to such a great extent that even after the doctor left the 
institute in 1902, he asked that he would be informed of her fate. By 1906, he was informed that she had 
completely succumbed to dementia and had died by April of that year. Given permission by the family, an 
autopsy was performed on Auguste. His post autopsy assessment would be the documentation of what has 
been identified to as the beta-amyloid plaques and neurofibrillary tangles [26].  
After presenting his finding to his fellow scientists, Dr. Emil Kraeplin, a coworker and a very 
prominent psychiatrist in Germany, urged Alzheimer to present his work at the next conference that same 
year. While the conference committee did not dedicate much text space of to the work, the disease began 
to garner momentum as more cases quickly followed. The disease remained essentially nameless until the 
8th version of Dr. Emil Kraeplin’s textbook was published in 1910 were he acknowledged the importance 
Dr. Alois Alzheimer’s discovery by publishing the history of Auguste Deter and proposing the name 
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“Alzheimer’s Disease [26].” Fig. 1 shows Auguste Deter, Dr. Alois Alzheimer, and Dr. Emil Kraeplin. 
Alzheimer’s disease is now identified as a leading causes of death in the U.S. and has been identified as 
one of the fastest growing causes of death as there has been an a 71 % increase in the percentage change 
for U.S causes of death from 2000 to 2013 [27]. HIV, heart disease, and stroke have dropped by 52%, 23%, 
and 14 % in the same time frame [27].  
 
Figure 1: (A) Patient Auguste Deter prior to her death in 1906. (B) The famed Dr. Alois Alzheimer. (C) The man 
who named the discovery as “Alzhiemer’s Disease,” Dr. Emil Kraeplin.  
 
2.2 Physiological Changes and Metal Ions in Alzheimer’s Disease  
 After one hundred years of research, Alzheimer’s disease (AD) has yet to be to be cured but 
significant research has been placed into understanding the governing components. The discussion of AD 
always covers two major physiological changes: senile plaque formation and neurofibrillary tangle 
formation. These formations have been identified to be influenced, to some degree, by the concentration of 
certain metal ions.  The potential link of senile plaques and neurofibrillary tangles to metal ions creates an 
opportunity for the proposed broader spectrum multi-modality. The PET component can and has been 
capable of imaging the physiological onset of the plaques and tangles but the metal ion concentrations have 
never been assessed simultaneously in a living subject. The development of an XFET system could provide 
(A) (B) (C) 
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this opportunity and the integration of PET and XFET could provide some clarification as to exact role and 
concentration level metal ions play in vivo. A brief introduction is provided to explain what is currently 
understood about AD.  
The initial indicators of AD are often seen on the behavioral level. Individuals afflicted with AD 
often exhibit issues with memory, uncertainty of time and place, and agitation in some cases. The numerous 
post mortem studies performed on symptomatic patients has readily identified the formation of plaque like 
depositions throughout the grey matter of the brain. These senile plaques have long since been identified as 
a characteristic physiological marker of AD. The impact of these plaques is assumed negative but there still 
exists much uncertainty as to the exact role they have.  
 Senile plaques are the aggregation of a misfolded protein known as β-amyloid (Aβ). To better 
understand Aβ, researchers have attempted to develop models for the governing formation mechanisms. 
These models currently point to the transmembrane protein named Amyloid Precursor Protein (APP). Being 
a transmembrane protein, a portion of the protein exists both within the intracellular environment and in 
the extracellular environment. APP must be acted upon through enzymatic cleavage to be freed from the 
cell membrane. Research into the enzymes which execute the cleavage has shown that APP can undergo 
two different post cleavage pathways as shown in Fig. 2 [28].  
 APP has three specific cleavage sights and therefore has three cleavage enzymes known as α-
secretase, β-secretase, and γ-secretase. Each cleavage enzyme is responsible for specific sight on APP but 
the initial enzymatic cleavage is critical to the pathway which APP undergoes.  When α-secretase acts upon 
APP, a portion of the protein is freed from the membrane. This protein is named sAPPα and, even if it is 
not fully understood, is generally assumed to have a positive impact on neuronal growth [28]. This pathway 
does not produce the aggregation of Aβ resulting in senile plaques. When β-secretase acts instead of α-
secretase, the pathway associated with AD is initiated. First, β-secretase cleaves APP and produces sAPPβ 
in the extracellular environment. Second, γ-secretase cleaves APP’s mid membrane site which frees the Aβ 
protein chain from the cellular membrane. Now Aβ floats freely in the extracellular fluid with the potential 
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to aggregate with the process driven by the levels of metal ions such as Cu2+, Fe2+, and Zn2+ [29]. The 
aggregated form results in plaques which bind to the grey matter of brain tissue.  
 
Figure 2: The two pathways for cleaved APP. In the event, hat α-secretase cleaves the transmembrane protein, plaque 
formation is currently believed not to be possible. If the other pathway is initiated by the cleaving performed by β-
secretase, and γ-secretase, then senile plaque formation may occur in the extracellular environment [28].  
 
 Fig. 3 shows the general regions of plaque deposition throughout the brain in the three separate 
stages. Stage A shows low levels of Aβ beginning to form deposits on the neocortical regions of cerebral 
cortex. The frontal, temporal, and occipital lobe are all potential targets for deposition. The hippocampal 
formation remains unaffiliated in this initial stage. Stage B shows an increase in aggression of aggregate 
formation. The majority of neocortex begins to observe medium density Aβ deposits. The only regions of 
the neocortex which may remain free include sensory and motor sections. Hippocampal formation begins 
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to observe deposition in the CA1 of the startum. By State C, the neocortex is fully afflicted. The 
hippocampal formation does not show a significant increase in the number of Aβ [30].  
 
Figure 3: The above shows the 3 stage Aβ onset identified by H. Braak et al. It should be understood that the majority 
of Aβ aggregation falls upon the neocortical regions of the brain [30].  
 
 During the onset of senile plaque formation, an equally important physiological phenomenon is 
observed. Originally discussed as neurofibrillary tangles (NFTs), NFTs are now understood to be the 
product of tau proteins and cellular microtubules. Microtubules exist within the cytoplasm of cells and are 
critical to the cellular function such mitosis, cell movement, and genetic regulation. Microtubules are 
stabilized by tau proteins. When AD sets in, the tau proteins become hyperphosphorylated and this results 
in the destabilization of the microtubule pathways. Tau proteins begin to aggregate causing microtubules 
to form tangles. Some very early studies hinted at the role of aluminum in tau aggregation but questions 
still remain regarding the metal’s role [31-33]. In Fig. 4, the onset of NFTs is shown in a three stage onset 
similar to that of Aβ. Unlike Aβ, the onset of NFTs does not show equally aggressive onset in the neocortex. 
Instead, the entorhinal cortex show the initial development of NFTs. This initial region is critical in the 
9 
 
formation of memory, and sleep. It serves as an intermediate connection between the neocortex and the 
hippocampal formation .The formation of NFTs by the intermediate stage becomes increasingly dense in 
the entorhinal cortex with some spread toward the neocortex. By late stages, the neocortex shows medium 
density NFT presence, and high density NFTs in the entorhinal region.   
 
Figure 4: From the same publication from H. Braak, NFTs were study and represented in a three stage process. Unlike 
Aβ, the NFT formation seems to heavily favor the entorhinal cortex until later stages of the disease [30].  
 
 
2.3 The Transgenic Mouse Model and In Vivo Imaging 
The birth of non-human small animal experimental subjects was supplied with early interest in 
understanding deoxyribonucleic acid (DNA) repair mechanism. The exploitation of Non-Homologous End 
Joining (NHEJ) and the Homologous Recombination (HR) showed great potential for the first attempts at 
manipulating genes. With various models proposed for HR (the Holliday model, and the Meselson-Radding 
model), it was not until 1981, when the double strand break model was proposed, that HR began to be 
considered for transgenic animal generation. Work by many individuals, specifically M. Cappachi, began 
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the exploration of incorporating genetic material into the embryonic stem cells of animals by HR. This 
simultaneously showed that genome editing was possible, and that animals could be manipulated to exhibit 
human disease.  
TABLE 1: Comparative list of AD based Mouse Models and the Phenotype Timeline 
  
With an understanding in hand of the neuropathology and genetic manipulation slowly emerging, 
the necessity for high resolution in vivo imaging became ever present. Toward the late 1900s, three key 
modalities saw rise for non-invasive imaging for preclinical and clinical investigation: MRI, SPECT and 
PET. MRI was hailed for its non-ionizing imaging capability but criticized for its low sensitivity. SPECT 
and PET varied between high resolution and high sensitivity but generally not ideally selected due to the 
presence of radiation. However, it was PET that eventually became the prominent imaging modality for 
AD mouse models due the development of the Pittsburg Compound B radio-imaging radiotracer in 2004 
which showed high affinity binding for amyloid plaques [20]. The imaging method was only limited by the 
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spatial resolution of scintillation crystals being around 1.4 mm. The poor resolution coupled with the size 
of a mouse brain (~10 mm) resulted in need for further improvements in imaging technology.   
Since then, many new models have been developed through the genetic manipulation of small 
animals. Table I shows three common models now used for nuclear AD imaging studies (Tg2576, 3xTg, 
and APP/PS1). These models have been highly studied, specifically the promising APP/PS1 model for 
viability [34]. The phenotype should be noted for each different model because the latency in phenotype 
onset as well as the degree of the model’s completeness are markers of the model’s quality. For example, 
the APP/PS1 model requires 6 weeks for plaque formation to be present in the cortex and 6 months for 
plaque to be seen in the hippocampus. The Tg2576 model requires 11-13 months for plaques to be seen in 
the brain at all.  
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CHAPTER 3. GOVERNING PHYSICS IN IMAGING 
3.1 X-ray Fluorescence: Photoelectric Absorption, Discrete Orbital Transitions, and Emission Edges 
 It is possible to force atomic radiation through the use of an external source rather than relying 
solely on the natural decay of a radioisotope. Using an external source, the incoming radiation can cause 
the excitation or ionization of a selected material. Electrons orbiting the nucleus of atom exist within 
discretized shells named K, L, M and N with K being closest to the atom’s nucleus and N being the furthest. 
It is necessary to create a vacancy within the orbital such that a higher level electron falls to replace the 
emitted photoelectron. This is possible when photoelectric absorption occurs with an incident energy which 
exceeds the electron binding energy as shown on the left in Fig. 5. Photoelectric absorption is defined in 
Equation 1 as, 
𝐸𝑒− = ℎ𝑓 −  𝜙          (1)  
where 𝐸𝑒− is the kinetic energy of the photoelectron, ℎ is Planck’s constant, 𝑓 is the frequency of the 
incident photon and 𝜙 is the electron binding energy.  
 When the emitted photoelectron escapes, the vacancy leaves behind a non-preferred energy 
configuration. Therefore, an electron from a higher orbital falls to replace the vacancy to achieve a stable 
energy configuration. This transition requires that energy be emitted in the form of an electromagnetic 
wave. As the orbital shells in an atom have strict configurations, the emission is a discrete characteristic 
energy for that atom. Therefore, it is possible to force atoms to fluoresce, and identify the atom based on 
its characteristic emission.  
Given multiple orbitals exist within the construct of the atom, it is possible to detect multiple 
different characteristic emissions based on the allowed shell transitions for a single atom. The probability 
of interaction, as shown for cortical bone in Figure 5, generally drops as a function of energy but there are 
spikes in the attenuation curve which are indicative of a sharp increase in the photoelectric absorption for 
a certain shell of the atom which is called the edge of that shell. This absorption increase is observed at the 
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X-ray energy just above the level of energy required to cause the excitation of the orbital’s electron. If 
specific energy of emission is desired, it is best to have an incident source slightly above the edge’s energy.   
 
Figure 5: (LEFT) The Rutherford-Bohr model of the atom representing the discrete nature of electron transitions as 
a result of photoelectric absorption. (RIGHT) Mass attenuation plot for cortical bone. Two edges can be observed in 
the plot [35, 36].  
 
3.2 Positron Emission and Annihilation 
 PET experiments which are carried out require the injection of radioactive substance into the animal 
or person of interest. This modality specifically exploits the formation of two near co-linear photons to form 
a line of response (LOR) from the electronic collimation achieved by the 511 keV annihilation photons.  
When an atom undergoes positron decay, it undergoes a reaction shown in Equation 2,  
𝑁𝑎11
22 →  𝑁𝑒10
22 +  𝑒+ +  𝜈𝑒               (2) 
where Na-22 decays to Ne-22 through the emission of a positron 𝑒+ and a neutrino 𝜈𝑒. The positrons 
produced have a continuous energy spectrum. As the positron passes through a material, inelastic collisions 
with electrons cause the positron to lose momentum. Upon achieving near zero momentum, the positron 
will cause a mass to energy conversion with an electron called annihilation. Two annihilation photons will 
be formed with any access momentum added as a conserved momentum vector to the newly formed 511 
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keV gamma rays. The production of these gamma rays is explained by Einstein’s mass-energy equivalence 
shown in Equation 3,  
𝐸 =  𝑚𝑜𝑐
2               (3) 
where E is the equivalent energy of the rest mass defined as 𝑚𝑜 and the conversion is performed by the 
multiplication of the speed of light defined as 𝑐. The annihilation process is shown in Fig. 6.  
 
Figure 6: Positron emission results from an unstable parent nucleus which the number of protons to the 
neutrons is unfavorable. A proton decays to form a neutrino and positron. The positron propagates until 
enough energy is lost for annihilation to occur. The annihilation of the positron with an electron produces 
two near co-linear 511 keV gamma events [37].  
 
 Ultimately, the spatial resolution of PET imaging is limited by two physical factors. The positron 
range and the residual moment transfer cause challenges to the overall imaging resolution of a PET system. 
First, the emission of a positron with a non-zero energy results in a displacement from the point of decay. 
Given the non-discrete nature of the energy as well, the resulting image resolution is degraded through 
blurring. The second challenge arises from the small amount of energy that is passed to the annihilation 
events. As the direction of the momentum is conserved, the annihilation events are not entirely collinear. 
In application, there is an increasing offset error caused by the non-collinearity as a function of detector 
ring diameter. This also can result in poorer spatial resolution and increased noise in the reconstructed 
image.  
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3.3 Compton and Rayleigh Scattering 
 When photoelectric absorption or annihilation do not occur, it is not uncommon to observe a 
scattering event. Scattering can be classified into two different forms: elastic and inelastic. Elastic scattering 
observes the conservation of the incident and scattered energy, and is common referred to as Rayleigh 
scattering. Alternatively, inelastic scattering observes a change between the incident and scattered energy 
of photon and is referred to as Compton scattering. In this case, some of the energy of incident photon is 
deposited in a recoil electron. Compton scattering is defined in Equation 4,  
𝜆𝑓 − 𝜆𝑖 =  
ℎ
𝑚𝑜𝑐
(1 − cos(𝜃))           (4) 
with the incident wavelength defined as 𝜆𝑖, the scattered wavelength defined as 𝜆𝑖, the angle of scatter as 
𝜃, ℎ as Planck’s constant, 𝑚𝑜 as the rest mass of an electron, and 𝑐 as the value of the speed of light.  
 
Figure 7: An incident photon may undergo inelastic scattering and deposit a portion of its energy into an 
orbiting electron. The angle of scattering is directly related to the amount of energy the electron will receive. 
If enough energy is deposited into the electron, the electron can be freed from its orbital, also causing a 
vacancy [38].  
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  CHAPTER 4. X-RAY EXPERIMENTAL MATERIALS AND METHODS 
4.1 Benchtop X-ray Fluorescence Emission Tomography Experimental Design 
  A prototype benchtop system was developed (as sketched in Fig. 8) for imaging metal content 
within biological specimens. The lower plane subsystem was for X-ray fluorescence imaging, while the 
upper plane subsystem allowed for standard radiography and computed tomography imaging, which 
provides useful information for alignment and attenuation correction. The sample would have to be 
translated between planes in order to take advantage of each portion of the experiment setup.  
 
Figure 8: Sketch of the dual planer experimental design for the XFET system. The sample could be 
translated vertically between the XRF setup and the CT setup. A monochromatic source used on the lower 
plane with an Andor CCD positioned at 90 degrees to this beam.  
 
The lower plane XFET subsystem contained the primary analytical X-ray source, an X-ray optical 
systems (XOS) X-beam, whose X-rays were focused and monochromatized with a doublecurved crystal 
monochromator and then collimated through a pinhole. This led to a circular pencil beam of X-rays of 
diameter approximately 100 µm. This source generates a flux of 1.55 𝑥 107 photons/s/mm of 17.4 keV (Mo 
K X-rays) photons at a focal distance of 20.4 cm, or 1.2 𝑥 105 photons/s within the 100 µm circular pencil 
beam. For XFET data acquisition, we used a commercial X-ray CCD detector, Ikon-L (DO-936 N), from 
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Andor Technology, Belfast, U.K. [38]. The detector has pixels of size 13.5 µm x 13.5 µm, which leads to 
a total surface area of 2.76 cm x 2.76 cm. For this measurement, the vertical shift speed was set to 76 µs 
with a horizontal shift frequency of 1 MHz. Pixel binning was used to optimize spectral performance. A 
single-slit aperture was placed in front of the Andor CCD detector, as shown in Fig. 9. The slit size was set 
and measured at 50 µm. The upper plane CT subsystem contains a standard polychromatic X-ray source 
from Oxford Instruments (Apogee 8000 series), which has a maximum tube potential of 50 kVp and a 
maximum tube current of 1.0 mA. The detector was a flat panel X-ray detector (Varian 1313 [39]) with 
pixels 127 µm x 127 µm in size. The detector has a total active area of 13 cm x 13 cm. This detector is 
placed at 36.23 cm from the rotational sample, and the sample is placed 22.55 cm from the source, which 
yields a source-to-detector distance of 58.78 cm. The sample holder itself is placed on a 5-dimension 
scanning system that is composed of two Newport stages, two Velmex stages, and a Micronix rotational 
stand. The necessity for a 5-dimensional system is derived from the need to control the CT magnification 
of the sample, the sample alignment with the CT, the rotational scanning during CT, the line-by-line 
scanning for fluorescence imaging, the fluorescence imaging magnification, and the sample alignment with 
the emission aperture of our Andor camera.  
  
Figure 9: (LEFT) Top down view of the XFET system. (RIGHT) Camera, slit and sample positioning.  
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4.2 Benchtop X-ray Fluorescence Emission Tomography Image Formation 
The geometry of XFET image formation is shown schematically in Fig. 10 on the left. The pencil 
beam stimulates emission of characteristic X-rays as it passes through the object, depicted here as three 
cylindrical tubes corresponding to the physical test object to be described in the next section. The slit 
collimator creates a mapping between small segments along the pencil beam and vertical columns of the 
detector. A typical acquired slit image is shown in Fig. 10 on the right, where it can be observed that only 
a fraction of the detector is actively used. Summing the detected image vertically (i.e., collapsing over the 
rows) and reversing the resulting vector allows one to directly estimate the elemental distributions along 
the illuminated line, without the need to solve a tomographic reconstruction problem. By translating the 
object horizontally through the illumination beam, a 2D image of the slice can be built up, line by line. 
Vertical translation can allow for the acquisition of additional slices to create a 3-D image.  
 
Figure 10: (LEFT) Conceptual representation of photons from a triple-tube sample propagating through 
the slit. (RIGHT) Photons generate the expected flipped projection. Photons are only geometrically limited 
in the horizontal direction and are free to project anywhere along the vertical direction to produce the slit 
projection.  
The achievable spatial resolution for a given slice will be determined by the illumination beam 
extent (100 µm spatial resolution as determined by the beam size) in one dimension and by the blurring 
introduced by the finite slit in the other. Due to the selected small sample size, the highly focused and well-
collimated beam changes in beam size across the sample are negligible. The specific geometry of the slit, 
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camera, and tubes is illustrated in Fig. 10 on the left. The magnified extent of the slit in the beam plane is 
62.9 µm. 
4.3 Imaging Phantom and Osmium-Stained Zebrafish 
This hardware was used to perform two separate experimental studies. The first imaging study 
involved a simple phantom comprising three capillary tubes filled with solutions: one a 25.0% (w/w) 
aqueous solution of sodium bromide, one a 25.0% (w/w) aqueous solution of iron (II) sulfate, and the last 
a 25.1% (w/w) aqueous solution of copper (II) nitrate. Each tube had an inner diameter of 0.798 mm and 
an outer diameter of 1.092 mm. The second sample was a five-day-postfertilization zebrafish embryo that 
was sacrificed, fixed, and stained with 1% osmium tetroxide and embedded in the resin Embed-812. The 
sample had been previously prepared for X-ray histology experiments. The zebrafish was approximately 2 
mm in diameter and 14 mm tall. The resin encasement was approximately 3.4 mm in diameter. The 
experiments were performed with 5000 frames per pencil beam illumination position with 2 s of exposure 
time per frame, yielding a total of 5 hours per line when including readout time. To form a complete 2D 
image, the tube was translated linearly through 24 positions separated by 100 µm, and the osmium stained 
zebrafish was translated through 12 positions separated by 100 µm. 
4.4 X-Ray Photon Detection and Algorithm for Single-Photon Counting 
The Andor detector employed is not natively a photon-counting detector. To obtain energy 
information about individual events, we operate in a mode in which frames are read out rapidly enough that 
only a few isolated events are expected in each frame. This allows identification of individual X-ray events 
and determination of the deposited energy after careful correction and calibration. In order to obtain an 
accurate energy response from the CCD detector, we have developed a single-photon counting routine to 
compensate for several physical factors that could degrade the energy information and to determine the 
energy deposition from each individual X-ray interaction. Given the small pixel size (13.5 µm x 13.5 µm 
binned to 27 µm x 27 µm) and the very thin depletion layer (15 µm) of the CCD detector used in this 
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experiment, X-ray photons interacting in the detector could result in a signal charge being shared by 
multiple adjacent pixels. In addition, long acquisitions could potentially lead the detector response to 
change with time or temperature. The implemented single X-ray detection algorithm seeks to determine 
accurate single photon energy information as follows. 
 1. 200 dark frames are collected from the CCD.  
2. From the 200 background frames, a per-pixel average is calculated along with the average over 
all CCD pixels.  
3. In order to minimize the influence of hot pixels, each per pixel average is compared with the 
overall CCD mean. The per-pixel average is replaced with the CCD mean if the pixel average falls more 
than three standard deviations outside of the camera’s noise. The resulting mean is used as the first offset 
subtraction.  
4. A second iteration is performed after the initial offset subtraction. Each pixel in every 
background frame is reanalyzed. Since the noise of the camera follows a known Gaussian distribution, 
individual background frames for a given pixel with values that do not adhere to the distribution are not 
considered for just that pixel for that frame as they have either been influenced by background radiation or 
are hot (per frame behavior is not considered in the first iteration, only average behavior across all frames). 
A new true background is recalculated per pixel, and this offset is used. 
5. Pixels that are constantly identified to not meet the criteria in the first and second iteration are 
recorded and have their offset calculated and subtracted to account for the hot behavior.  
6. 2-D local maximum searching is performed across each data frame to identify single photon 
events. The sum over a 3 x 3 region around each maximum is computed.  
7. The background is then continuously monitored to ensure no baseline drifting and corrected if 
so. For each local maximum (a single photon event on the detector surface), this method yields the detector 
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x-position, the detector y-position, the peak energy value, the summed energy value, and the source frame 
number.  
 
Figure 11: The electrons formed from photoelectric absorption repel each other and force spread to occur 
which may reach out to adjacent pixels. This charge sharing effect can potentially degrade the overall 
energy resolution achievable with the CCD. In order to correct for this, a fixed region around the peak 
around the pixel with the highest energy is summed. This summing results in the capture of the majority of 
the shared charge. The above figure shows an example of intensity and spread difference from two different 
photoelectric events.  
 
Fig. 11 shows an example of the single photon events on the detector plane. Plotting the spectra 
using the summed energy values derived from the single-photon counting algorithm reveals that processing 
is necessary to improve energy resolution. Fig. 12 shows a scatter plot of the summed energy versus the 
peak energy divided by the summed energy. It can be seen that as the ratio deviates from 1, which represents 
full energy deposition into a single pixel, the peak shifts downward. The peak shifting needs to be corrected 
in order to achieve the ideal horizontal alignment visible in the bottom of Fig. 12. The correction is done 
by partitioning the x-axis into a selected number of bins. In this case, 20 bins were used, and the copper K-
alpha peak was selected as the reference peak for the correction. In each bin, the peak maximum position 
of the copper K-alpha peak was located through Gaussian fitting along the -axis. As a result of doing this, 
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the offset from the unity case is known per bin. Therefore, all ratios can be vertically shifted with respect 
to the unity ratio to align the spectrum, and ultimately correct for charge-sharing. 
 
Figure 12: As charge sharing is a challenge in pixelated detectors, correction need to be implemented to 
account for the fraction loss of charge. The above show the before after vertical shift correction performed 
to correct to the expected peak charge to summed charged ratio of 1. 
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CHAPTER 5. PET EXPERIMENTAL MATERIALS AND METHODS 
5.1 PET Cathode Waveforms 
 When energy is deposited within the CdTe detector crystal, electron-holes pairs are produced. In 
the presence of an electric field, the electrons and holes drift either toward or away from the cathode 
depending on polarity of bias. When charge moves in an electric field, the displacement of charge results 
in the formation of a waveform signal on the cathode. Given that both holes and electrons are influenced 
by the field, multiple components can be measured on the cathode as shown in Fig. 13. It is understood that 
this waveform can provide additional benefits to our detectors so a design has been developed to incorporate 
this waveform which is presented in the next section.  
 
Figure 13: Detector 1 and Detector 2 cathode and anode signal recorded from the HPWF detector. There 
are three bending points in the cathode. The first (A) represents the generation of electron-hole pairs in the 
crystal, the second (C) is arrival of the electrons at the anode, and the final (D) is the arrival of the holes at 
the cathode. The amplitude of the electron contribution (B) is the subtraction of the first and second bending 
point amplitudes while the hole contribution is the subtraction of the second and third bending point.  The 
total amplitude is shown as (E).  
 
 
5.2 Hybrid Pixel-Waveform CdTe PET Detectors 
The transition from the current state of the art in PET system performance has required the exploration 
of semiconductor detectors with small pixelated elements. It has been anticipated that the use of small pixels 
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could dramatically improve the intrinsic resolution of detectors of scintillation based systems. Yet, 
semiconductor detectors are not without challenge. While semiconductor detectors could potentially 
provide improvement in spatial resolution and energy resolution of the current commercial state of the art, 
semiconductors suffer from poor timing resolution, charge trapping, and the need for means for DOI. 
Therefore, to achieve high resolution broad spectrum imaging, the work presented here explores the use of 
readout system which combines both cathode and anode information. The addition of the cathode waveform 
opens the possibility of use corrections to be implemented.   
The current effort has been focused on developing a CdTe detectors readout with a novel hybrid-pixel 
waveform readout circuitry shown in Fig. 14. This technique was designed to alleviate several intrinsic 
hurdles for using highly pixelated semiconductor detectors for PET imaging. This work focuses on the use 
of a modified 2048-channel 2-D CMOS ASIC for reading out small anode pixels of 350 µm x 350 µm in 
size, and a high speed digitizer for sampling the cathode and anode waveform induced by each individual 
event. Several modules were fabricated and tested for coincidence detection of the 511 keV gamma rays 
produced from annihilation process. Each single module is composed of a CdTe crystal of 1.1 cm x 2.2 cm 
with a depth of 2 mm. The crystal overlays an anode partitioned into 32 x 64 pixels with each single pixel 
being 350 µm x 350 µm in size. The HPWF detector approach offers several benefits for PET imaging: 
 Depth of interaction information can be derived from the cathode waveform acquired using the HPWF 
method.  
 Improved energy resolution utilizing the cathode waveform information, which allows for reliable 
derivation of the total energy deposition regardless any charge loss or sharing on the pixelated anode. 
 Improved timing resolution by using the cathode signal waveform from initial electron migration through 
the CdTe crystal.  
 Simplified readout circuitry due to the reduced burden of extracting all critical information from the small 
anode pixels. With this technique, the anode readout circuitry only needs to provide spatial position in X-
Y directions.  
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Figure 14: (A) Pixelated elements of the anode. (B) The CdTe crystal bump bonded to the surface of the 
anode. (C) First generation 4.5 cm x 4.5 cm, 8 ASIC detector design used for the experiments performed in 
this thesis. (E) Each ASIC can function independently and the electronics for readout are heavily simplified. 
(F) The total volume occupied by the simplified readout can be reduced to not much more than the area of 
the CdTe crystal.  
 
 
5.3 Hybrid Pixel-Waveform CdTe PET Experimental Design 
 The experimental studies were carried out using two active CdTe hybrids in a benchtop system 
shown in Fig. 15. The detector firmware was modified to allow coincidence detection, between the two 
detectors, and a dedicated coincidence control unit was implemented using a Xilinx Spartan FPGA. The 
readout time per pixel was minimized to 125 ns, and the number of pixels read out on each hybrid was 
firmware-selectable from 512 to 2048.  
The two HPWF detectors were placed around a 4-D (X-Y-Z-Rotation) stage. Three dimensions 
were for the translation of the axis of rotation, using Newport motors, so that the selected radioactive source 
was centered in the system field of view (FOV). The final dimension used a Micronex rotational motor in 
order to simulate a detector ring. Signals induced in the cathode waveform were shaped with a NIM shaper 
(Ortec FTA 820) and fed into a constant fraction discriminator (Ortec 584). Events exceeding the threshold 
were sent to the coincidence unit with a resolving time window of 50 ns. For coincidence events, the cathode 
signals from both detectors were directed to an external ADC running at 200 M samples/sec. This ADC 
2
.2
 c
m
 
S
u
p
er
-c
o
m
p
ac
t 
P
C
B
s 
(A) (B) 
(C) 
(E) (F) 
26 
 
stored all events in a circular buffer in order to preserve the cathode waveform generated prior to shaped 
triggering. The schematic of the triggering and readout system are provided in Fig. 16. 
 
Figure 15: System triggering is controlled by the FPGA coincidence control unit (Xilinx Spartan-3E). The 
4-D stage used in the experiments allowed source alignment and the simulation of a multi-detector ring 
through rotation. (B) Ortec analog shaping and CFD electronics were used to process the Amptek A250 
preamplifier signals generated from coincidence events. 
 
 
Figure 16: In the block diagram provided, cathode signals from detector 1 and detector 2 were sent to an Amptek’s 
A250 preamplifier. The waveform was digitized by our Gage ADC while the timing output was shaped by Ortec’s 
FTA820. The shaped ouput was sent to an Ortec 584 constant fraction discriminator (CFD). If the signal arriving at 
the CFD exceeded 30 mV, a TTL pulse from the CFD would be directed to the Ortec 414a coincident unit. A Xilinx 
Spartan-3E control FPGA would determine if the coincidence event from the 414a was true or not. Connections 
between the FPGA and the HPWF PET system were made using P-MOD BNC adapters. 
 
5.4 Hybrid Pixel-Waveform CdTe PET Point Source and Capillary Tubes 
The very first PET experiments performed using a design setup relied on the use of a 10 µCi Na-
22 point source with a diameter of 250 µm, and three separate microcapillary tubes of approximately ~300  
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µm inner diameter of a total a activity of approximately 18 µCi . The point source was positioned with a 
1.305 mm offset, and the capillary tubes were separated approximately by 1.5 mm. Both sets of experiments 
rotated a full 360 degrees partitioned into 40 positions. Each position was sampled for a full hour. The point 
source reconstruction was used to provide an early determination of the potential intrinsic spatial resolution 
of the system while the capillary tubes provided insight in the number counts necessary for a good 
reconstruction of the data.  
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CHAPTER 6. EXPERIMENTAL RESULTS 
6.1 XFET Single Photon Counting Spectra 
The results of the spectral correction algorithms for the tube phantom can be seen in Fig. 17. The 
raw, uncorrected spectrum is shown in the left panel, and the corrected spectrum is shown in the right panel. 
For bromine, these comprise a 𝐾𝛼 peak at about 11.9 keV, and the peak 𝐾𝛽1 at 13.2 keV. For copper, we 
see the 𝐾𝛼 copper peak (a blend of 𝐾𝛼1  at 8.048 keV and 𝐾𝛼2  at 8.027 keV) and the 𝐾𝛽1  peak at 8.905 
keV. Finally, for iron, only the joint peak is barely visible at 6.4 keV. The tube containing iron, which has 
the lowest emission energies of the three elements, was inadvertently placed furthest from the detector and 
thus it suffered tremendous attenuation effects. Therefore, no further mention of iron is made. 
In addition to being more distinct after correction, the various peaks are also more quantitatively 
accurate. The intensity of the bromine 𝐾𝛼 emissions should be about 7.3 times higher than the 𝐾𝛽 emissions. 
After correction, the 𝐾𝛼 peak is about six times higher than the peak, consistent with expectations. Finally, 
in addition to the characteristic X-ray peaks, there is a distinct single Compton scatter peak at 16–17.5 keV, 
spanning a relatively broad range of energies because of the range of scattering angles compatible with the 
system geometry. There is also a broad but low multiple Compton scatter background. 
The second experimental study, with the osmium-stained fish, produced the raw and corrected 
spectra in Fig. 18. The osmium characteristic X-rays seen in this spectrum are the L-peaks, since the K-
edge of osmium is well above the 17.5 keV beam energy, while the L-edges are in the 10–13 keV range. 
The peaks observed are 𝐿1 7.82 keV , 𝐿𝛼 8.91 keV , 𝐿𝛽 10.35 keV , and 𝐿𝛾 12.09 keV . The scattering peak 
was again observable. 
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Figure 17: (LEFT) The uncorrected, raw triple-tube spectrum from the CCD detector. (RIGHT) The 
Gaussian corrected spectrum which shows resolvable peaks. 
 
 
Figure 18: (LEFT) The uncorrected osmium zebrafish spectrum. (RIGHT) Corrected spectrum. Multiple osmium 
peaks are visible along with the Compton scattering peak. 
 
6.2 XFET Imaging Results 
 In Fig. 19, the results obtained from the capillary tube are presented. Iron did not yield a strong 
signal as the iron did not stay in solution. The results from bromide and copper are shown. The images 
obtained from copper and bromide without attenuation correction are shown in Fig. 19a and Fig. 19c. The 
samples appear to have very strong self-attenuation as the emission X-ray photons must pass through the 
capillary glass and the sample itself. In the provided images the detector is orientated at the bottom of the 
30 
 
image and, due to such a positon, the intensity of Fig. 19a and Fig. 19c can be seen to have a stronger signal 
toward the bottom of the image. Attenuation corrected images are also provided (work performed by a 
collaborator) are shown in Fig. 19b and Fig. 19d. These images obviously improve drastically in image 
uniformity. The applied energy windows are shown in the previous energy spectra.  
 
Figure 19: (A) Attenuation uncorrected capillary image of the bromide solution. (B) Attenuation corrected 
bromide capillary solution. (C) Copper solution with no attenuation, and (D) Attenuation corrected copper 
solution. An anomaly was visible in the copper data seen as a small streak but the cause was not determined.  
 
 In Fig. 20 and Fig. 21, imaging results from the osmium stained zebrafish sample are shown. Again 
in this image, self-attenuation of the sample is very clearly observed in Fig. 20a. The camera again is located 
at the bottom of the image and the strongest signal can be observed closest to the CCD camera. The weakest 
signal can be seen in the top right as both the incident beam (coming from the right side of the figure) and 
the emission are being attenuated by the sample. The osmium zebrafish attenuation correction is provided 
in Fig. 20b. The internal structure of the zebrafish can better visualized with the attenuation correction. Fig. 
21 shows the results of isolating the Compton scattering of the incident 17.4 keV X-ray beam used for 
exciting the sample. It was possible to visualize the resin in which the zebrafish was encased within.  
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Figure 20: (A) Raw count image obtained from the osmium stained zebrafish. (B) Attenuation corrected 
osmium stained zebrafish.  
 
Figure 21: Image acquired when only energies of the incident beam scattering was isolated. Heavy 
attenuation of the scattered events was visible in this image.   
 
6.3 HPWF PET Imaging Results 
 The acquired PET data was considered with and without DOI data. Fig. 22 shows the reconstruction 
of the point source data with positional separations ranging from 600 µm down to 400 µm. In the absence 
of DOI, visualization of the point source is not possible and the shape of the point source is clearly distorted. 
When DOI correction was applied, the shape of the reconstructed point source improved. Initial results 
shown here indicate that the system may be able to achieve sub 400 µm resolution but further verification 
is required.  
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Figure 22: (LEFT) Reconstruction of point source experimental data and varying separations. No DOI 
correction was performed on the data. (RIGHT) DOI corrected point source reconstruction data.  
 Fig. 23 shows the reconstruction of the three capillary tubes. Sub-figures A, C, E, and G show the 
sinogram data and sub-figures B, D, F, and H are the actual images for the capillary tubes for each 
reconstructed condition. While 400,000 events were collected from the experiment, the data was 
reconstructed using a subsets of 20,000 events, 40,000 events, 80,000 events, and 200,000 events. The 
image quality varied directly as a function of the number of events and the minimum events identified for 
sufficient image quality was 80,000 events.  
 
Figure 23: (A, B) 20,000 event sinogram and reconstruction. (C, D) 40,000 event sinogram and 
reconstruction. (E, F) 80,000 event sinogram and reconstruction. (G, H) 200,000 sinogram and 
reconstruction.  
No DOI Information  
 
DOI Information Included  
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
(G) 
(H) 
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CHAPTER 7. SUMMARY AND CONCLUSIONS 
 The work in this thesis performed preliminary evaluation of two separate modalities for potential 
integration such that broader spectrum imaging could be achieved for the purpose of extracting more 
biologically relevant information. The experimental data from that XFET results indicated that the methods 
implemented could prove that elements such as copper and bromide were visible. These results were further 
cemented by the ability to visualize the zebrafish staining. The experimental data from the CdTe PET 
experiments provided an indication of the maximum achievable resolution with the selected pixelated 
semiconductor detectors. The results seem favorable for a potential integration for small animal 
neurodegenerative imaging.  
 Given these results, XFET/PET could potentially serve as dual modality system but many elements 
would still need to be addressed. The concentrations imaged by the XFET system were far too high to be 
biology relevant. The concentrations were on the order of 250 mg/ml but biologically relevant 
concentrations exist on the microgram scale. Additionally, the self-attenuation serves a natural shield 
against elements deeper in the tissue and this would require the use of higher energy incident and emission 
X-rays at the potential challenge of causing more dose. While PET did show a good potential achievable 
resolution, the images provided were under very simple conditions with no real background noise being 
provided to the experiment. The long acquisition time and minimal number of counts collected for the 
capillary tubes indicated that the system sensitivity would also need to be addressed.  
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CHAPTER 8. FUTURE WORK 
 Given the true complexity of such modalities, the wisest course of action would be to proceed with 
a single modality. The information and background presented in this thesis does provide reason to pursue 
the idea of broader spectrum multi-modality development but each modality is not well understood. 
Therefore, my future work will only focus on understanding only CdTe PET. This includes better 
understanding the function of HPWF detectors, the potential limitations of semiconductor material in PET, 
the system timing resolution, the system energy resolution, and depth of interaction. I also currently have 
great interest in exploring the waveforms in CdTe PET and, from my intuition, feel that much more 
information can be extracted then what is visible upon initial inspection.  
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